CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2022 GI Fellow Board of Advisors
Embassy of Education  
Slide Library Webcasts Abstract Library LiverQ Academy National Conference
 
 
| Slide Library
Resource Library
 
HE Slides
   Released: 2022
test
Expert Insights: Improving Outcomes in Patients with Chronic Liver Disease
46 slides
 
 
   Released: 2020
test
Complications of Cirrhosis
65 slides
 
 
Pediatric Liver Disease Slides
   Released: 2022
Cholestatic Pruritus Across the Age Spectrum: What Are You Missing?
94 slides
 
 
   Released: 2021
test
New Innovations for Children with Rare Cholestatic Liver Disease: Expert Perspectives on Diagnostic and Treatment Advances in PFIC and ALGS
61 slides
 
 
Cirrhosis Slides
   Released: 2022
test
Improving Health Outcomes in the Cirrhotic Patient
57 slides
 
 
   Released: 2022
test
Clinical and Economic Impact of Chronic Liver Disease and Cirrhosis on the U.S. Healthcare System
22 slides
 
 
   Released: 2022
test
Management Gaps in the Treatment of Chronic Liver Disease
18 slides
 
 
   Released: 2022
test
Chronic Care Management Approaches in Chronic Liver Disease
19 slides
 
 
   Released: 2022
test
The Prevention of Rehospitalization of the Chronic Liver Disease Patient
20 slides
 
 
   Released: 2022
test
Chronic Liver Disease and the Burden on Community Practice
20 slides
 
 
   Released: 2022
test
Chronic Liver Disease Quality Assurances and Indicators for the Practicing Healthcare Provider
27 slides
 
 
   Released: 2022
test
Innovative Models of Chronic Liver Disease Care
21 slides
 
 
CLD Health Outcomes Slides
   Released: 2022
test
Improving Health Outcomes in the Cirrhotic Patient
57 slides
 
 
   Released: 2022
test
Clinical and Economic Impact of Chronic Liver Disease and Cirrhosis on the U.S. Healthcare System
22 slides
 
 
   Released: 2022
test
Management Gaps in the Treatment of Chronic Liver Disease
18 slides
 
 
   Released: 2022
test
Chronic Care Management Approaches in Chronic Liver Disease
19 slides
 
 
   Released: 2022
test
The Prevention of Rehospitalization of the Chronic Liver Disease Patient
20 slides
 
 
   Released: 2022
test
Chronic Liver Disease and the Burden on Community Practice
20 slides
 
 
   Released: 2022
test
Chronic Liver Disease Quality Assurances and Indicators for the Practicing Healthcare Provider
27 slides
 
 
   Released: 2022
test
Innovative Models of Chronic Liver Disease Care
21 slides
 
 
HBV Slides
   Released: 2021
Webcast
HBV Alliance: Expert Recommendations on Managing Patients with Chronic Hepatitis B
56 slides
 
 
   Released: 2021
Webcast
Acute HBV
17 slides
 
 
   Released: 2021
Webcast
Chemotherapy/Reactivation
26 slides
 
 
   Released: 2021
Webcast
Current Management of Chronic Hepatitis B
30 slides
 
 
   Released: 2021
Webcast
Epidemiology of HBV
34 slides
 
 
   Released: 2021
Webcast
Evaluation of the Patient With Chronic HBV
26 slides
 
 
   Released: 2021
Webcast
Everything Old Is New Again!
41 slides
 
 
   Released: 2021
Webcast
Extrahepatic Manifestations of Hepatitis B
34 slides
 
 
   Released: 2021
Webcast
HBsAg Quant HBV Genotyping HBV RNA Quant Where We Are in 2020
41 slides
 
 
   Released: 2021
Webcast
HBV & Hepatitis D (Delta)
26 slides
 
 
   Released: 2021
Webcast
HBV and Liver Cancer
34 slides
 
 
   Released: 2021
Webcast
HBV and NAFLD
35 slides
 
 
   Released: 2021
Webcast
HBV Coinfection With HCV or HIV
35 slides
 
 
   Released: 2021
Webcast
HBV: New Therapies & Clinical Trials
37 slides
 
 
   Released: 2021
Webcast
Hepatitis B Screening: CDC, AASLD, USPSTF
24 slides
 
 
   Released: 2021
Webcast
Hepatitis B: Treatment Endpoints
27 slides
 
 
   Released: 2021
Webcast
Hepatitis B: Update on Treatment Guidelines
27 slides
 
 
   Released: 2021
Webcast
How to Diagnose Hepatitis B
25 slides
 
 
   Released: 2021
Webcast
Immunization for HBV
31 slides
 
 
   Released: 2021
Webcast
Management of HBV: New Data
26 slides
 
 
   Released: 2021
Webcast
Natural History of HBV
39 slides
 
 
   Released: 2021
Webcast
Treatment of Hepatitis B: Controversies 2020
63 slides
 
 
   Released: 2021
Webcast
Update on Hepatitis B
54 slides
 
 
   Released: 2021
Webcast
WHO Hepatitis Elimination Targets
46 slides
 
 
   
     
HCC Slides
   Released: 2022
test
New Advances in HCC Therapies
61 slides
 
 
   Released: 2021
test
Management and Treatment of HCC is Optimized in a Multidisciplinary Liver Tumor Board
61 slides
 
 
   Released: 2021
test
Sequence of Currently Approved Systemic Therapies for HCC: From First Line to Second Line and Beyond
53 slides
 
 
   Released: 2021
test
The Role of Precision Medicine in the Management and Treatment of HCC
33 slides
 
 
   Released: 2021
test
Integration of Immuno-Oncology to Improve HCC Outcomes: Immune Checkpoint Inhibition and Potential Synergies with Interventional Radiology and Radiation Oncology
30 slides
 
 
   Released: 2021
test
Non-Cirrhotic Risk Factors for HCC in Patients with NAFLD
35 slides
 
 
   Released: 2021
test
Recommendations to Optimize Surveillance of HCC
33 slides
 
 
   Released: 2021
test
Epidemiology and Surveillance for Hepatocellular Carcinoma
31 slides
 
 
   Released: 2021
test
Current Surgical Resection for Primary Liver Malignancies
87 slides
 
 
   Released: 2021
test
Second Line Therapies in HCC
30 slides
 
 
   Released: 2021
test
Thermal Ablation for HCC
96 slides
 
 
   Released: 2021
test
Transarterial Therapies for HCC: TACE and Y90
38 slides
 
 
   Released: 2021
test
Imaging of HCC Surveillance, Diagnosis, and Prognosis
38 slides
 
 
   Released: 2021
test
Update on the Front-Line Management of Advanced HCC
33 slides
 
 
   Released: 2021
test
Liver Transplantation for Patients with Hepatocellular Carcinoma
33 slides
 
 
   Released: 2021
test
HCC Research Update: From Bedside to Bench-side and Back to Bedside
26 slides
 
 
   Released: 2020
test
How to Approach HCV Treatment in Patients With HCC - DAA Before or After Liver Transplantation
40 slides
 
 
   Released: 2020
test
Down-Staging of Hepatocellular Carcinoma Before Liver Transplantation: Tumor Burden, Alpha-Fetoprotein and Wait Time Predict of Tumor Biology
45 slides
 
 
   Released: 2020
test
HCC Risk Biomarkers 2021: State of the Art and Future Perspective
65 slides
 
 
   Released: 2020
test
Novel Treatments and Emerging Targets for Hepatocellular Carcinoma (HCC)
52 slides
 
 
   Released: 2020
test
Surgical Options for Treatment of HCC - Resection vs. Liver Transplantation (LT)
74 slides
 
 
   Released: 2020
test
Interventional Oncology: Hepatocellular Carcinoma
63 slides
 
 
   Released: 2020
test
Update on HCC Clinical Trials: Barcelona HCC Criteria and Phase III Data
60 slides
 
 
   Released: 2020
test
Disparities in Linkage to Care for HCC
35 slides
 
 
   Released: 2020
test
HCC Surveillance in an Era of Biomarkers: Application of State-of-the-Art Tools
59 slides
 
 
   Released: 2020
test
Overview of Treatment Approaches to Hepatocellular Carcinoma
47 slides
 
 
   Released: 2020
test
Diagnosis and Staging of HCC
38 slides
 
 
   Released: 2020
test
Global HCC Trends: Implications for Prevention
54 slides
 
 
   Released: 2020
test
Changing Epidemiology of HCC in the U.S.
55 slides
 
 
   Released: 2020
test
Populations at High Risk for HCC in the U.S. - Implications for Clinical Practice
59 slides
 
 
   Released: 2019
test
Epidemiology HCC Innovations
21 slides
 
 
   Released: 2019
test
Intra-Arterial Therapies
25 slides
 
 
   Released: 2019
test
Immunotherapy for HCC and Emerging Treatments
72 slides
 
 
   Released: 2019
test
Liver Transplant for Hepatocellular Carcinoma
22 slides
 
 
   Released: 2019
test
Systemic Therapy for Liver Cancer
46 slides
 
 
   Released: 2019
test
Imaging and Biomarkers in HCC: Diagnosis and Surveillance
29 slides
 
 
   Released: 2019
test
Defining Outcomes of Hepatocellular Carcinoma therapy
51 slides
 
 
   Released: 2019
Webcast
Determining Hepatocellular Carcinoma Staging:Liver Disease Staging, Performance Status and RECIST Criteria
38 slides
 
 
   Released: 2019
Webcast
Surveillance for Hepatocellular Carcinoma
37 slides
 
 
   Released: 2018
test
Hepatology News Tonight: Managing Complication of Cirrhosis
57 slides
 
   
HCV Slides
   Released: 2021
Webcast
Triple E for HCV: Engagement, Education and Eradication - ASAM
68 slides
 
 
   Released: 2020
Webcast
Triple E for HCV: Engagement, Education, and Eradication
70 slides
 
 
   Released: 2020
test
Hepatitis C: Screening, Barriers and Access to Therapy
28 slides
 
 
   Released: 2019
Webcast
AATOD Conference
159 slides
 
 
   Released: 2019
Webcast
Triple E for HCV Satellite Symposium - NCCHC
81 slides
 
 
   Released: 2019
Webcast
Hot Topics in Cirrhosis
120 slides
 
 
   Released: 2019
Webcast
Triple E for HCV Satellite Symposium - ASAM
75 slides
 
 
   Released: 2019
Webcast
Hepatology News Tonight Managing Complications of Cirrhosis
129 slides
 
 
   Released: 2018
test
HCV Advances 2018
51 slides
 
 
   Released: 2018
test
Hepatology News Tonight: Managing Complication of Cirrhosis
57 slides
 
 
   Released: 2018
Webcast
Hepatitis Elimination Symposium and Workshop
96 slides
 
 
   Released: 2017
Webcast
HCV Advances 2017
54 slides
 
 
   Released: 2017
Webcast
Expert Perspectives: Highlights on HCV from EASL 2017
61 slides
 
 
   Released: 2016
Webcast
Expert Perspectives: Best of HCV - 2016 Spring Update
82 slides
 
 
     
NASH Slides
   Released: 2023
test
NASH PATHway to Treatment
Michael Charlton, MD
Rohit Loomba, MD
Maru E. Rinella, MD
97 slides
 
 
   Released: 2023
test
Advances in NAFLD/NASH
Kris V. Kowdley, MD
55 slides
 
 
   Released: 2022
test
 
   Released: 2022
test
 
   Released: 2022
test
Pearls and Pitfalls: Update on emerging therapies in NASH
Michael Charlton, MD & Rohit Loomba, MD
97 slides
 
 
   Released: 2021
test
The Puzzle in Hepatorenal Syndrome Management
Hugo E. Vargas, MD
40 slides
 
 
   Released: 2021
test
COVID-19 and Managing Liver Disease
K. Rajender Reddy, M.D.
33 slides
 
 
   Released: 2021
test
Alcohol-Associated Liver Disease
Michael R. Lucey MD
43 slides
 
 
   Released: 2021
test
Chronic Hepatitis B and D: Emerging Concepts and Treatment
Robert G Gish MD, FAASLD, AGAF, FAST
42 slides
 
 
   Released: 2021
test
Management of Refractory Hepatic Encephalopathy
Jasmohan S. Bajaj, MD
41 slides
 
 
   Released: 2021
test
Hepatitis C: Elimination Strategies in the US
David Bernstein, MD, FAASLD, FACG, FACP, AGAF
43 slides
 
 
   Released: 2021
test
Management of Hepatocellular Carcinoma in 2021
Laura Kulik, MD
45 slides
 
 
   Released: 2021
test
Hot Topics In Pediatric Liver Disease
Rohit Kohli, MBBS, MS
35 slides
 
 
   Released: 2021
test
Thrombocytopenia in CLD
Robert S. Brown, Jr., MD, MPH
32 slides
 
 
   Released: 2021
test
Cholestatic Liver Disease: Current Management and Emerging Therapies
Kris V. Kowdley MD
36 slides
 
 
   Released: 2021
test
Emerging Therapies in NASH
Stephen A Harrison, MD, FACP, FAASLD
32 slides
 
 
   Released: 2021
test
Identifying High Risk NASH Patients Using Noninvasive Techniques (NITs)
Mazen Noureddin, MD, MHSc
42 slides
 
 
   Released: 2021
test
Burden of NASH: Why Do We Need to Care?
21 slides
 
 
   Released: 2021
test
NASH Screening and Diagnosis in Primary Care and Endocrinology Practice Settings: The Role of NITs
52 slides
 
 
   Released: 2021
test
NASH Screening and Diagnosis in Specialty Clinics: The Role of Radiologic Modalities, Serum Fibrosis Tests and Algorithm
40 slides
 
 
   Released: 2021
test
Treatment Endpoints: Clinical vs Regulatory Endpoints
39 slides
 
 
   Released: 2021
test
Combination Therapies in NASH: What's Promising?
21 slides
 
 
   Released: 2021
test
Lifestyle Modification and Current Treatment Regimens for NAFLD
29 slides
 
 
   Released: 2021
test
New Targets for Emerging Therapies in NASH
26 slides
 
 
   Released: 2020
test
Imaging as an Outcome and Endpoint for Clinical Trials of NASH
29 slides
 
 
   Released: 2020
test
Clinical Management of NASH: Diet and Nutrition
41 slides
 
 
   Released: 2020
test
The Comprehensive Global Burden and Impact of NASH
32 slides
 
 
   Released: 2020
test
NAFLD and Cardiovascular Disease
43 slides
 
 
   Released: 2020
test
Imaging as an Outcome and Endpoint for Clinical Trials of NASH
29 slides
 
 
   Released: 2020
test
Challenges in Management and Clinical Trials of NASH in Children
26 slides
 
 
   Released: 2020
test
Weight Loss in NASH: Role of Weight Loss Medications and Surgery
17 slides
 
 
   Released: 2020
test
Why NASH and Exercise?
43 slides
 
 
   Released: 2020
test
Is Histologic Fibrosis Assessment an Appropriate Endpoint / Reference Standard for Clinical Trials?
25 slides
 
 
   Released: 2020
test
NASH and Diabetes Linkage: Where do we go from here?
42 slides
 
 
   Released: 2020
test
Serum Biomarkers and Clinical Algorithms in NASH: Utility in Clinical Trials and Clinical Practice
49 slides
 
 
   Released: 2020
test
Best Practices in NASH Management and Current Status of Drug Development
37 slides
 
 
   Released: 2020
test
Imaging as an Outcome and Endpoint for Clinical Trials of NASH
35 slides
 
 
   Released: 2020
test
NASH: Current Approach and When Will New Treatment Options Be Available?
39 slides
 
 
   Released: 2018
Webcast
NASH 2018
61 slides
 
 
   Released: 2016
Webcast
Get Ready for the Global Epidemic of NASH: Evolving Diagnosis and Treatment Strategies
66 slides
 
 
   Released: 2015
Webcast
Best of the Liver Summit: PBC, NAFLD/NASH and HCV
78 slides
 
 
   Released: 2015
Webcast
Hepatology Update: New Developments in PBC, NAFLD & NASH
77 slides
 
 
   Released: 2015
Webcast
THE LIVER SUMMIT
89 slides
 
 
PBC Slides
   Released: 2022
test
PBC: Diagnosis and Current Management Strategies
41 slides
 
 
   Released: 2020
test
Clinical Insights Into the Management of Primary Biliary Cholangitis (PBC)
53 slides
 
 
   Released: 2020
test
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current and Emerging Treatments
48 slides
 
 
   Released: 2019
Webcast
Hot Topics in Cirrhosis
120 slides
 
 
 
Hepatorenal Syndrome Slides
   Released: 2022
test
Emerging Guidance for Managing Hepatorenal Syndrome
83 slides
 
 
   Released: 2021
test
Expert Perspectives on the Management of Hepatorenal Syndrome
58 slides
 
 
   Released: 2021
test
New Treatment Advances & Current Management Approaches in Acute Kidney Injury-Hepatorenal Syndrome (AKI-HRS)
62 slides
 
 
   Released: 2020
test
Hot Topics in Cirrhosis: A Case-Based Approach to Hepatorenal Syndrome (HRS) and Acute Kidney Injury (AKI) in Chronic Liver Disease
102 slides
 
 
   Released: 2019
Webcast
Hot Topics in Cirrhosis: A Case-Based Approach to Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS)
91 slides
 
 
   Released: 2019
Webcast
Current and Emerging Management Approaches for the Patient with Hepatorenal Syndrome (HRS)
21 slides
 
 
   Released: 2019
Webcast
Hot Topics in Cirrhosis
120 slides
 
 
   Released: 2019
Webcast
Hepatology News Tonight Managing Complications of Cirrhosis
129 slides
 
 
 
 
 

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2023 GI Fellow Board of Advisors

Other Resources

Journal Abstracts
Hep C Link to Care

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2023 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.